Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ALEXION PHARMACEUTICALS, INC.

(ALXN)
  Report
SummaryQuotesChartsNewsRatingsCompanyFinancials 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Sector news Biopharmaceuticals
01/18Morgan Stanley Adjusts Price Target for Biogen to $360 From $363, Maintains Overweight ..
MT
01/18HC Wainwright Adjusts Biogen's Price Target to $270 from $452, Keeps Buy Rating
MT
01/18Biogen on Cusp of 'Change' in Wedbush View as Medicare's Proposed Plan for Alzheimer's ..
MT
01/18S.Korea stocks hit 7-week closing low ahead of LGES IPO
RE
01/14BofA Securities Adjusts Biogen's Price Target to $245 From $275, Maintains Neutral Rati..
MT
01/14South Korean Stocks Fall for Second Day as Bank of Korea Raises Base Rate; Samsung Biol..
MT
01/13Samsung Biologics to Start Building Fifth Plant to Meet Higher Biopharmaceutical Produc..
MT
01/13S&P Downgrades Biogen Rating To 'BBB+' From 'A-' On Declining Sales, Lower Growth Prosp..
MT
01/13Biogen Wants Final Decision on Aduhelm Alzheimer's Drug to be 'Coverage With Restrictio..
MT
01/13Biogen eyes potential acquisitions - Stat News
RE
01/13Biogen Reportedly Works with Goldman to Explore Possible Acquisitions
CI
01/13Guggenheim Downgrades Biogen to Neutral From Buy, Lowers Price Target to $202 From $290
MT
01/13Health Care Stocks Mixed Pre-Bell Thursday
MT
01/13Biogen says yet to speak with CMS about coverage of Alzheimer's drug
RE
01/13S.Korean stocks end lower on options expiry; BOK in focus
RE
01/12AFTER HOURS WATCH LIST SCORECARD : Srlp, rc, biib
MT
01/12US Stocks Edge Higher as Markets Digest Inflation Data
MT
01/12Biogen shares slide as Medicare proposal restricts coverage of Alzheimer's treatments
RE
01/12Equities Higher Midday With Crude Oil After Inflation Hits Four-Decade High
MT
01/12MIDDAY REPORT : US Stocks Higher With Crude Oil After Inflation Hits Four-Decade High; Tre..
MT
01/12Biogen Down Nearly 9%, on Track for Lowest Close Since October 2019 -- Data Talk
DJ
01/12Health Care Stocks Mixed Premarket Wednesday
MT
01/12Biogen Shares Fall Premarket on Medicaid Coverage Plans for Aduhelm
DJ
01/12Wedbush Cuts Biogen's Price Target to $195 From $249 on Lowered Aduhelm Uptake Estimate..
MT
01/12Medicare to Cover Biogen Alzheimer's Drug Only for Patients in Approved Clinical Trials..
MT
01/12Biogen Calls on Medicare to 'Change' Draft Decision to Cover Alzheimer's Drug Only for ..
MT
01/12Piper Sandler Lowers Biogen to Neutral From Overweight, Price Target to $216 From $362
MT
01/12Mizuho Cuts Biogen's Price Target to $207 From $270, After CMS' 'Scathing Evidence Revi..
MT
01/12South Korean Stocks Jump After US Fed Chief’s Less Hawkish Testimony; Hanmi Pharm..
MT
01/12S.Korean stocks post best day in 6 weeks on Powell remarks
RE
01/11MT NEWSWIRES AFTER HOURS WATCH LIST : Srlp, rc, biib
MT
01/11Medicare Plans to Cover Biogen's Alzheimer's Drug Only for Patients in Approved Clinica..
MT
01/11Biogen - To Continue To Urge CMS To Align Medicare Coverage For Class Of Amyloid-Direct..
RE
01/11U.S. Medicare plans to cover Biogen Alzheimer's drug only for trial patients
RE
01/11U.S. Government Medicare Program Plans To Cover Alzheimer's Treatments Including Biogen..
RE
01/11U.S. Medicare program plans to cover Biogen's Aduhelm, with some conditions
RE
01/11Biogen Sliding 6.5% in After-Hours - Medicare to Restrict Access to Alzheimer's Drug Ad..
MT
01/11Needham Adjusts Biogen's Price Target to $328 From $386, Keeps Buy Rating
MT
01/11Hong Kong shares close unchanged; Fed policy in focus
RE
01/11China stocks fall as virus worries, Fed rate hike bets weigh; Hong Kong up
RE
01/07S&P 500 Starts 2022 With 1.9% Weekly Loss, Led by Real Estate, Technology, Health Care;..
MT
01/07Truist Securities Adjusts Biogen Price Target to $343 From $502, Maintains Buy Rating
MT
01/06Morgan Stanley Adjusts Biogen's Price Target to $363 from $440, Keeps Overweight Rating
MT
01/06RBC Lifts Price Target on Biogen to $243 From $242, Maintains Sector Perform Rating
MT
01/05China stocks fall after hawkish Fed minutes; property, consumption drop
RE
01/05Wuxi Biologics Repurchases Nearly $503 Million Worth of Shares; Shares Fall 7%
MT
01/05InnoCare Pharma Says Unaware of Reasons for 'Unusual Fluctuations' in Share Price
MT
01/04Biogen Exercises Option With Ionis to Develop, Commercialize BIIB115/ION306 to Treat Sp..
MT
01/04Biogen Inc. Exercises Option with Ionis Pharmaceuticals, Inc. to Develop and Commercial..
CI
01/03S.Korea stocks begin 2022 with mild gains on trade data boost
RE
1  2  3  4  5  6  7  8  9  10Next